Key takeaways:
Preeclampsia is a condition during pregnancy marked by high blood pressure and other signs of kidney or liver damage. It can result in serious or deadly consequences if not recognized and treated.
Black women are more likely to be diagnosed with preeclampsia and also have higher death rates from it. This may be due to social, cultural, genetic, and environmental factors.
You can’t prevent preeclampsia, but the risk of death can be reduced with weight control, blood pressure control, and proper prenatal care. A screening test is now FDA approved to help discover at-risk pregnancies in the third trimester.
Preeclampsia is a common condition that affects 1 in 25 pregnancies in the U.S. It’s the most serious form of high blood pressure in pregnancy and can have severe complications. In many cases, preeclampsia is mild. But it can be life-threatening. In fact, preeclampsia is a leading cause of death for pregnant mothers — especially Black women.
While there’s no way to prevent preeclampsia, early detection and treatment can help save lives. Let’s take a closer look at preeclampsia, what makes it so dangerous, and ways your provider can screen for it.
Preeclampsia is a high blood pressure condition that develops in pregnancy. Preeclampsia usually occurs in the latter stages of pregnancy. But it can occur as early as week 20 of pregnancy. In rare cases, it can develop up to 48 hours after delivery.
There’s no known cause for preeclampsia, though many theories exist. Experts believe that it may be the result of a problem with the placenta that develops over time.
Along with high blood pressure, there are often signs of organ damage in preeclampsia. Preeclampsia will commonly affect the liver, kidney, or brain. It can also cause problems with the placenta.
If untreated, preeclampsia can progress to eclampsia — the most severe form of the condition. Eclampsia involves the brain, and seizures and coma can occur.
The only cure for severe symptoms of preeclampsia is to deliver the baby. This can also lead to a premature birth if preeclampsia develops before the pregnancy is full-term.
Preeclampsia is a diagnosis based on multiple new high blood pressure readings:
Systolic pressure (top number): 140 or higher and
Diastolic pressure (bottom number): 90 or higher
Your provider will also perform a physical exam with ultrasound and check your urine and blood tests. This is to look for protein in the urine, evidence of major organ damage in the blood, and blood flow issues to the growing baby.
The diagnosis of preeclampsia is confirmed if there’s evidence of high blood pressure along with at least one of the following:
Protein in the urine
Organ damage (evidenced by symptoms or abnormal kidney, liver, brain tests)
Thrombocytopenia (low platelet count)
Placenta problems or growth problems with the developing baby
Rates of preeclampsia are 60% higher in Black women than white women. It’s not entirely clear why there’s a huge difference in the rates for this condition. Experts believe there may be several factors linked to the disparity. Let’s take a closer look.
Many social factors appear to affect the high rates of preeclampsia in Black women. These include issues like:
Lack of healthcare access: A lack of proper prenatal care prevents preeclampsia being diagnosed at early stages.
Unconscious bias: Biases about pregnant Black women can affect decision-making by healthcare providers.
High rates of stress: Stress from systemic racism and discrimination may play a role.
Lack of social support: Black women are less likely to have support systems in place.
Black women also have higher rates of other conditions that are risk factors for developing preeclampsia. Dr. Kimberly Moran Turner, an OB-GYN physician at Johns Hopkins Community Physicians, says “Black women are at especially high risk of preeclampsia because many have underlying high blood pressure.”
And some people have health conditions before pregnancy that can increase the risk of preeclampsia. Examples include:
Diabetes
Obesity
Genetic predisposition (APOL1 variant)
Preeclampsia is dangerous because it can have immediate and long-term health effects for both mother and baby. Let’s start by reviewing short-term effects from preeclampsia.
Short-term fetal effects can include:
Preterm birth
Stillbirth (pregnancy loss after week 20 of gestation)
Poor fetal growth or low birth weight
Low amniotic fluid
Short-term maternal effects can include:
Increased risk of postpartum heart failure
Kidney failure
Seizures
Abnormal heart rhythm
Most of the long-term fetal effects are a direct result of preterm delivery, and many will improve with time. These effects can include:
Increased risk of impaired cognitive function or attention deficit disorder
Chronic lung disease
Feeding difficulties leading to uncoordinated suck and swallow
Long-term maternal effects can include:
Increased risk of cardiovascular disease
Increased risk of chronic high blood pressure
Increased risk of chronic kidney disease
There are no known ways to prevent preeclampsia. But there are some measures that might help lower the risk of preeclampsia in some people.
Women without prenatal care are seven times more likely to die from preeclampsia. Prenatal care visits improve the likelihood of earlier diagnosis. And it allows for regular monitoring of mom and the growing baby.
Blood pressure screening and urine testing is a routine part of prenatal care. Subtle changes could be detected when a pregnant mother has access to proper care.
There is now an FDA-approved screening test for preeclampsia. It is based on research of two proteins that are linked to women with severe preeclampsia.
The screening test looks at the ratio of these proteins in women who are in the hospital for high blood pressure in weeks 23 to 25 of pregnancy. With 96% accuracy, it can help to identify mothers most likely to develop severe preeclampsia within a 2-week timeframe.
Aspirin started at 12 weeks gestation for some groups at high risk of preeclampsia may help to prevent preeclampsia. Mothers at high risk have almost 25% lower rates of preeclampsia when taking aspirin during pregnancy.
Despite being at high risk, studies show that Black women are less likely to be offered aspirin. Dr. Turner says it’s important to speak up. “Self-advocacy is so important for pregnant women.” Make sure you feel heard at your medical visits. Talk with your healthcare provider about your risk for preeclampsia and if you need to consider aspirin during pregnancy.
Preeclampsia is a serious high blood pressure condition in pregnancy. Black women are more likely to be diagnosed with preeclampsia and have much higher death rates. The reasons for this disparity are unknown, but it may be due to social and environmental factors.
Routine prenatal care, aspirin, and a new FDA-approved screening test may help lower the risk of preeclampsia in those at risk. Talk with your provider about your risk of preeclampsia and how to promote a healthy pregnancy.
American College of Obstetricians and Gynecologists Committee on Obstetric Practice. (2023). Low-dose aspirin use during pregnancy.
American Heart Association. (2023). Scheduled childbirth may greatly reduce preeclampsia, a leading cause of maternal death.
Blanchard, F. (2021). Risk factor identified for disease disproportionately affecting African Americans. Frederick National Laboratory for Cancer Research.
Boakye, E., et al. (2021). Nativity-related disparities in preeclampsia and cardiovascular disease risk among a racially diverse cohort of US Women. JAMA Network Open.
Centers for Disease Control and Prevention. (2022). What is stillbirth?
Fasanya, H. O., et al. (2022). A critical review on the use of race in understanding racial disparities in preeclampsia. The Journal of Applied Laboratory Medicine.
Fox, R., et al. (2019). Preeclampsia: Risk factors, diagnosis, management, and the cardiovascular impact on the offspring. Journal of Clinical Medicine.
Haßdenteufel, K., et al. (2022). Long-term effects of preeclampsia on maternal cardiovascular health and postpartum utilization of primary care: An observational claims data study. Archives of Gynecology and Obstetrics.
Henderson, J. T., et al. (2017). Screening for preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force: Introduction. Agency for Healthcare Research and Quality (US).
Ives, C. W., et al. (2020). Preeclampsia—Pathophysiology and clinical presentations: JACC state-of-the-art review. Journal of the American College of Cardiology.
Kattah, A. (2020). Preeclampsia and kidney disease: Deciphering cause and effect. Current Hypertension Reports.
Lu, H. Q., et al. (2019). Lasting effects of intrauterine exposure to preeclampsia on offspring and the underlying mechanism. AJP Reports.
MedlinePlus. (2022). Eclampsia.
Miller, A. K., et al. (2020). Association of preeclampsia with infant APOL1 genotype in African Americans. BMC Medical Genetics.
Preeclampsia Foundation. (2021). Cause of preeclampsia.
Preeclampsia Foundation. (2023). Thermo Fisher Scientific gets FDA clearance for preeclampsia risk assessment assays.
Saluja, B., et al. (2021). How implicit bias contributes to racial disparities in maternal morbidity and mortality in the United States. Journal of Women’s Health.
Thadhani, R., et al. (2022). Circulating angiogenic factor levels in hypertensive disorders of pregnancy. NEJM Evidence.
Wagner, L. K. (2004). Diagnosis and management of preeclampsia. American Family Physician.
Wong, M. S. (2022). Black pregnant people are less likely to be recommended aspirin prophylaxis for preeclampsia. American Journal of Obstetrics & Gynecology.